CVC Capital Partners plc (AMS:CVC)
Netherlands
· Delayed Price · Currency is EUR | Market Cap | 13.34B |
| Revenue (ttm) | 1.85B |
| Net Income (ttm) | 1.18B |
| Shares Out | 1.05B |
| EPS (ttm) | 0.77 |
| PE Ratio | 16.42 |
| Forward PE | 14.90 |
| Dividend | 0.47 (3.70%) |
| Ex-Dividend Date | May 14, 2026 |
| Volume | 1,844,100 |
| Average Volume | 1,723,543 |
| Open | 12.65 |
| Previous Close | 12.69 |
| Day's Range | 12.45 - 12.72 |
| 52-Week Range | 10.50 - 18.11 |
| Beta | 0.48 |
| RSI | 56.12 |
| Earnings Date | Jul 30, 2026 |
About CVC Capital Partners
CVC Capital Partners plc is a private equity and venture capital firm specializing in middle market secondaries, infrastructure and credit, management buyouts, leveraged buyouts, growth equity, mature, recapitalizations, strip sales, and spinouts. The firm makes investments in medium to large sized companies. It seeks to invest in fintech, healthcare, industrial, Education, telecommunications, information technology, electronics, biotechnology, medical, energy, chemistry, new materials, industrial automatisms, tech-enabled businesses such as hu... [Read more]
Financial Performance
In 2025, CVC Capital Partners's revenue was 1.85 billion, an increase of 18.53% compared to the previous year's 1.56 billion. Earnings were 1.18 billion, an increase of 425.14%.
Financial StatementsNews
Teleflex Stock Surges Over 8% In Pre-Market Trading: Here's Why
Teleflex Inc. (NYSE: TFX) shares jumped 8.22% to $135.00 in pre-market session on Wednesday, after private equity firms CVC Capital Partners and GTCR submitted a joint bid to take the medical device ...
CVC Capital Partners Shares Slip as Performance-Related Earnings Guidance Disappoints
The guidance overshadowed better-than-expected results for 2025, with the firm posting a 67% increase in realizations.
CVC Capital Partners Earnings Call Transcript: Q4 2025
Delivered record inflows, realizations, and earnings in 2025, with fee-paying AUM up 50% in two years and strong growth in credit, secondaries, and infrastructure. Strategic partnerships and acquisitions position the group for continued 10%+ AUM growth and robust earnings through 2028.
CVC earnings guidance disappoints, shares fall
Private equity firm CVC Capital Partners announced on Wednesday a lower near-term performance-related earnings (PRE) outlook than expected, sending its shares down.
DSM-Firmenich to Sell Animal Nutrition Unit to CVC in $2.6 Billion Deal
The sale to CVC Capital Partners marks the final step in its plan to fully focus on human nutrition, health and beauty.
DSM-Firmenich to sell animal health business to CVC Capital
Chemicals company DSM-Firmenich has agreed to sell its Animal Nutrition & Health business to CVC Capital for an enterprise value of around 2.2 billion euros ($2.6 billion), it said on Monday.
dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners
Press Release dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovat...
CVC Capital to buy Marathon Asset Management in $1.2B US credit push
Private equity firm CVC Capital has agreed to acquire 100% of US-based Marathon Asset Management in a transaction valued at up to $1.2 billion, marking a major expansion of its credit business in the ...
Smiths Group to Sell Screening Technology Unit to CVC Capital Partners For $2.6 Billion
The U.K. engineering company said that the completion is expected in the second half of 2026.
Europe's private equity giants tumble as U.S. bank lending fears spread
Shares in several high-profile private markets firms were in negative territory on Friday as concerns around credit stress in the U.S. spread to Europe. Officials at the IMF and ECB this week flagged ...
CVC Capital Partners Earnings Call Transcript: H1 2025
Strong H1 2025 results featured 14% growth in revenues and EBITDA, record fundraising, and robust investment returns. Fee-paying AUM reached EUR 140 billion, with significant expansion in credit, secondaries, and infrastructure. PRE and distributions are set to rise further.
CVC Capital Partners Transcript: AGM 2025
The AGM highlighted a landmark year post-IPO, with strong financial growth, record fundraising, and new fund launches. All resolutions, including a EUR 225 million dividend, were approved. The board remains selective on acquisitions and has no current plans for share buybacks.
CVC Capital Partners Earnings Call Transcript: H2 2024
2024 marked a record year with a successful IPO, 50% growth in fee-paying AUM, and strong investment performance, including 4x MoM and 30% IRR on exits. Outlook for 2025 is positive, with further EBITDA growth and continued expansion in private wealth and infrastructure.
CVC Capital Partners Earnings Call Transcript: H1 2024
Fee-paying AUM rose 45% to €142bn in H1 2024, driven by strong fundraising and new fund activations. Realizations and investment returns were robust, with private equity delivering 3.6x MOIC and 28% IRR. Guidance for revenue and margins remains unchanged.